NovaBay Pharmaceuticals
16 hedge funds and large institutions have $115K invested in NovaBay Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 1 closing their positions.
Holders
16
Holders Change
+4
Holders Change %
+33.33%
% of All Funds
0.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
3
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Citadel Advisors
Miami,
Florida
|
$38.3K |
| 2 |
HF
2
HRT Financial
New York
|
$22K |
| 3 |
TSS
3
Two Sigma Securities
New York
|
$12.5K |
| 4 |
4
Geode Capital Management
Boston,
Massachusetts
|
$11.3K |
| 5 |
5
Renaissance Technologies
New York
|
$26K |
Top Sellers
| 1 |
TRCT
1
Tower Research Capital (TRC)
New York
|
$5.03K |
| 2 |
WP
2
WealthPLAN Partners
Omaha,
Nebraska
|
$0 |
